IRIS
CAPURSO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.959
NA - Nord America 3.389
EU - Europa 2.159
SA - Sud America 1.331
AF - Africa 96
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.207
SG - Singapore 2.727
CN - Cina 1.682
BR - Brasile 1.146
HK - Hong Kong 851
IT - Italia 540
SE - Svezia 368
VN - Vietnam 279
RU - Federazione Russa 274
DE - Germania 267
GB - Regno Unito 147
FI - Finlandia 115
CA - Canada 94
AR - Argentina 85
IN - India 79
AT - Austria 76
PL - Polonia 73
NL - Olanda 69
MX - Messico 65
BD - Bangladesh 61
FR - Francia 60
ZA - Sudafrica 57
JP - Giappone 50
ES - Italia 46
TR - Turchia 39
ID - Indonesia 33
IE - Irlanda 29
EC - Ecuador 28
IQ - Iraq 27
LT - Lituania 21
PK - Pakistan 20
UA - Ucraina 18
VE - Venezuela 17
BE - Belgio 16
PY - Paraguay 16
UZ - Uzbekistan 15
RO - Romania 13
CO - Colombia 11
TW - Taiwan 11
UY - Uruguay 11
MA - Marocco 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
KE - Kenya 8
NP - Nepal 8
IR - Iran 7
JO - Giordania 7
AU - Australia 6
EG - Egitto 6
PE - Perù 6
SA - Arabia Saudita 6
TN - Tunisia 6
BH - Bahrain 5
CL - Cile 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HN - Honduras 5
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
OM - Oman 4
TH - Thailandia 4
AM - Armenia 3
CH - Svizzera 3
GT - Guatemala 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
PT - Portogallo 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
NI - Nicaragua 2
PA - Panama 2
SR - Suriname 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
Totale 12.938
Salva come PNG Salva come JPEG
Città #
Singapore 1.330
Dallas 923
Hong Kong 845
Ashburn 433
Shanghai 433
Hefei 348
Beijing 221
New York 162
Los Angeles 128
Milan 127
São Paulo 117
Ho Chi Minh City 102
Moscow 89
Boardman 87
Munich 86
Lawrence 85
Princeton 85
Nuremberg 83
Hanoi 64
Rome 62
Warsaw 62
Turku 48
Tokyo 47
Johannesburg 46
Helsinki 45
Montreal 44
Rio de Janeiro 42
Orem 39
Brooklyn 38
Santa Clara 38
Guangzhou 37
Stockholm 36
Vienna 35
London 33
Poplar 32
Amsterdam 30
Chicago 30
Denver 30
Atlanta 29
Dublin 28
Washington 28
Chennai 27
Seattle 27
Phoenix 26
Frankfurt am Main 25
Houston 25
Boston 24
Belo Horizonte 23
Ankara 22
Brasília 22
Lappeenranta 22
Manchester 22
Cesano Boscone 21
Mexico City 21
Curitiba 20
Assago 18
Majano 18
San Francisco 18
Toronto 18
Brescia 17
Columbus 17
The Dalles 17
Campinas 16
Porto Alegre 16
Shenzhen 16
Minneapolis 15
Bergamo 14
Jiaxing 14
Brussels 13
Da Nang 13
Hangzhou 13
Paris 13
Tashkent 13
Haiphong 12
Jakarta 12
Pune 12
Goiânia 11
Mumbai 11
Salvador 11
Secaucus 11
Thái Bình 11
Tianjin 11
Fortaleza 10
Montevideo 10
Ribeirão Preto 10
Santa Maria 10
Sorocaba 10
Caxias do Sul 9
Guarulhos 9
Miami 9
Querétaro 9
Aracaju 8
Biên Hòa 8
Contagem 8
Dhaka 8
Guarujá 8
Guayaquil 8
Jundiaí 8
New Delhi 8
Osasco 8
Totale 7.473
Salva come PNG Salva come JPEG
Nome #
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 123
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 117
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 116
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls 97
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 95
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 93
DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING 93
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 91
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 88
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 88
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 87
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 85
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 84
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 83
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 82
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 82
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 81
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 78
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 76
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 76
Genetic and non-genetic risk factors for early-onset pancreatic cancer 73
ENDOSCOPIC ULTRASOUND-GUIDED HYBRID THERM ABLATION (EUS-HTP) IN PATIENTS (PTS) WITH LOCALLY ADVANCED (LA) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A CASE-CONTROL COMPARATIVE SURVIVAL ANALYSIS 72
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 71
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 71
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 70
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 70
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 70
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 70
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA 70
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 69
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 69
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 67
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 66
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 66
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 66
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 66
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 66
European evidence-based guidelines on pancreatic cystic neoplasms 65
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 64
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 63
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 63
Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors 62
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 62
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 61
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 61
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 60
The impact of nutritional status on pancreatic cancer therapy 60
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 60
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 59
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 59
Urgent manifestations of immunoglobulin G4-related disease 59
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 59
ACUTE PANCREATITIS PATIENT REGISTRY TO EXAMINE NOVEL THERAPIES IN CLINICAL EXPERIENCE (APPRENTICE): AN INTERNATIONAL MULTICENTER CONSORTIUM FOR THE STUDY OF ACUTE PANCREATITIS 58
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 57
Alcohol and gastrointestinal cancers 57
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 57
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 57
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 57
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 57
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 57
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: An international multicentre study 57
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 56
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 56
Consensus guidelines on severe acute pancreatitis 56
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 55
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 55
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 55
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 55
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 54
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 54
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED STAGE. IV DIGESTIVE ENDOCRINE. TUMORS 53
Addendum 53
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 53
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 53
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 53
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 53
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 52
4. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis 52
Activation of MNK2/eIF4E Pathway by the Splicing Factor SRSF1 Supports Pancreatic Cancer Cell Survival to Genotoxic Stress 51
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 51
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 51
Artificial intelligence in EUS for autoimmune pancreatitis: Bias and real life 51
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 50
Risk factors for the occurrence of ampullary tumors: A case-control study 50
Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms 50
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 50
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 49
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 49
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 49
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 49
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 49
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review 49
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 49
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 49
ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium 49
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 48
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 48
Early onset pancreatic cancer. Risk factors, presentation and outcome 48
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 47
Totale 6.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 15 3 0 1 0 0 0
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20254.788 512 138 88 131 300 460 557 385 880 600 349 388
2025/20266.797 1.165 1.174 986 1.939 1.208 325 0 0 0 0 0 0
Totale 13.439